Strategies & Technologies Driving Drug Discovery to Market
Massive Accomplishment
February 2, 2009 12:21 pm | by Yingying Huang, PhD, Strategic Marketing Specialist, Thermo Fisher Scientific | Articles | CommentsHigh resolution, accurate mass LC-MS/MS technology combines with mass defect filtering software to improve the speed and efficiency of early-stage drug discovery and late-stage drug development.
When Size & Shape Matter
February 2, 2009 11:46 am | by Ben Lich, Product Manager, FEI Company Ulf Willen, Product Manager, Malvern Instruments Ltd. | Articles | CommentsSEM-based systems can give researchers a better look at sub-micron pharmaceutical particles.
GPCR Roundtable Participants
February 2, 2009 10:42 am | Product Releases | CommentsIn Depth: GPCR AnalysisMeet the scientists of Drug Discovery & Development magazine's GPCR Roundtable.
Can Human-animal Hybrids Generate Stem Cells?
February 2, 2009 10:12 am | News | CommentsAlthough human-to-human clones (human clones) and human-to-animal clones (hybrids) appear similar, the pattern of reprogramming of the donor human cell is dramatically different.
Make Your Own Miracles
February 2, 2009 9:36 am | by Rita C. Peters, Editorial Director | Articles | CommentsBailout. Blagojevich. Foreclosure. Furlough. There has not been a lot of “happy news” lately. Even peanut butter has had negative press.
Imaging Technologies to Study GPCR
February 2, 2009 9:21 am | Articles | CommentsIn Depth: GPCR AnalysisCompanies are beginning to develop imaging technologies to study GPCRs.
Genomic Studies for GPCRs
February 2, 2009 9:09 am | Articles | CommentsIn Depth: GPCR AnalysisGenetic or genomic approaches are used to validate targets of potential therapeutic interest. Find out how genomic approaches are used in identigying GPCR targets.
Crystallized GPCRs
February 2, 2009 8:58 am | Articles | CommentsIn Depth: GPCR AnalysisDrug Discovery & Development magazine conducted a roundtable discussion with industry scientists to answer questions about GPCR. Below are the answers to a question related to crystallizing GPCR.
Recombinant Systems for GPCRs
February 2, 2009 8:42 am | Articles | CommentsIn Depth: GPCR AnalysisRecombinant systems help do primary screens of GPCRs. Find out why recombinant systems are helpful in GPCR screening.
Millipore Acquires Guava Technologies
February 2, 2009 7:39 am | News | CommentsMillipore Corporation announced that it has entered into an agreement to acquire Guava Technologies.
Born to be Druggable
February 2, 2009 6:19 am | by James Netterwald, PhD, Senior Editor | Articles | CommentsIn Depth: GPCR Analysis Cellular location, function in physiology, and relevance in disease, are among the many factors that make GPCRs druggable targets.
Ablynx Generates Nanobodies against GPCRs
February 2, 2009 5:58 am | News | CommentsAblynx announced it has successfully generated Nanobodies against several GPCR receptors.
Wyeth Deal Could Mean NJ Drug Industry Job Cuts
February 2, 2009 5:34 am | by Victor Epstein, Associated Press Writer | News | CommentsThe state known as the nation's medicine chest is bleeding from sweeping job cuts to its high-paying pharmaceutical industry.
Improving Preclinical Testing with New Animal Models
February 2, 2009 5:23 am | by Mike May, PhD, Contributing Editor | Articles | CommentsA company can’t develop a new drug without animal models.
Surviving Difficult Times
January 30, 2009 12:01 pm | by Ted Agres, Contributing Editor | Articles | CommentsWhile no strangers to financial challenges, biotech and pharmaceutical companies are scrambling to find ways to weather the recession.
